Bayesian Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,661	Closed	-$290K	–	1049
2023 Q4	$290K	Buy	+12,661	New	+$290K	0.03%	524
2023 Q3	–	Sell	-9,211	Closed	-$254K	–	929
2023 Q2	$254K	Buy	+9,211	New	+$254K	0.03%	581